• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Braeburn KAM base

















Any base is too much for this dud. I would pay 20K plus commission. Hire rookies reps or old men who are desperate. Most reps could not stand Derkass talking for more than five minutes without resigning.